Patents by Inventor Natasa Strbo

Natasa Strbo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vectors and vaccine cells for immunity against Zika virus
    Patent number: 11666649
    Abstract: The present invention provides an expression vector, host cells, methods and kits for the treatment or prevention of a flavivirus infection in a subject.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: June 6, 2023
    Assignee: University of Miami
    Inventors: Natasa Strbo, Laura Romero
  • VECTORS AND VACCINE CELLS FOR IMMUNITY AGAINST ZIKA VIRUS
    Publication number: 20210290750
    Abstract: The present invention provides an expression vector, host cells, methods and kits for the treatment or prevention of a flavivirus infection in a subject.
    Type: Application
    Filed: October 10, 2017
    Publication date: September 23, 2021
    Inventors: Natasa STRBO, Laura ROMERO
  • IMMUNE-MEDIATED CORONAVIRUS TREATMENTS
    Publication number: 20210283242
    Abstract: The present invention provides an expression vector, host cells, methods and kits for the treatment or prevention of a coronavirus infection in a subject.
    Type: Application
    Filed: March 2, 2021
    Publication date: September 16, 2021
    Inventors: Jeff T. HUTCHINS, Natasa STRBO, Jeffrey WOLF
  • COMBINED CELL BASED GP96-IG-SIV/HIV, RECOMBINANT GP120 PROTEIN VACCINATION FOR PROTECTION FROM SIV/HIV
    Publication number: 20140286991
    Abstract: Compositions are provided comprising heat shock protein, immunoglobulins and retroviral antigens to induce systemic and mucosal immunity to infection from retroviruses such as Human Immunodeficiency Virus (HIV). Methods of treatment provided comprise administration of the compositions, which boost the immune systems response to the retroviral antigens or immunogens.
    Type: Application
    Filed: February 23, 2012
    Publication date: September 25, 2014
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Eckhard R. Podack, Natasa Strbo, Genoveffa Franchini, Monica Vaccari
  • HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY
    Publication number: 20140037682
    Abstract: Compositions of genetically engineered, secreted gp96 (gp69-Ig) induced strong mucosal and systemic immune responses and CD8 expansion that was independent of CD4 help. Immunization of patients with gp96-Ig immunization is especially attractive for induction of mucosal and systemic immunity to SIV/HIV and other diseases.
    Type: Application
    Filed: October 11, 2013
    Publication date: February 6, 2014
    Applicant: UNIVERSITY OF MIAMI
    Inventors: ECKHARD R. PODACK, NATASA STRBO
  • TNFR25 AGONISTS TO ENHANCE IMMUNE RESPONSES TO VACCINES
    Publication number: 20120029472
    Abstract: TNFR25 compositions enhance the immune response against antigens. Administration of TNFR25 agonists was found to enhance tumor rejection, responses against viral diseases and other infectious organisms.
    Type: Application
    Filed: December 21, 2009
    Publication date: February 2, 2012
    Applicant: University of Miami
    Inventors: Eckhard R. Podack, Natasa Strbo, Vadim Deyev, Taylor Schreiber
  • HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY
    Publication number: 20110223196
    Abstract: Compositions of genetically engineered, secreted gp96 (gp69-Ig) induced strong mucosal and systemic immune responses and CD8 expansion that was independent of CD4 help. Immunization of patients with gp96-Ig immunization is especially attractive for induction of mucosal and systemic immunity to SIV/HIV and other diseases.
    Type: Application
    Filed: November 23, 2009
    Publication date: September 15, 2011
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Eckhard R. Podack, Natasa Strbo